Autologous EBV-specific Cytotoxic T Cells in Systemic Lupus Erythematosus: An Innovative Phase I/IIa Clinical Trial

被引：0
|
作者：
Enfrein, Antoine [1 ]
Clemenceau, Beatrice [2 ]
Saiagh, Soraya [3 ]
Bressollette, Celine [4 ]
Amoura, Zahir [5 ]
Vie, Henri [2 ]
Hamidou, Mohamed [1 ]
机构：
[1] CHU Nantes, Med Interne, Nantes, France
[2] Univ Nantes, Inserm U1232, Nantes, France
[3] CHU Nantes, Unite Therapie Cellulaire & Genique, Nantes, France
[4] CHU Nantes, Lab Virol, Nantes, France
[5] Hop La Pitie Salpetriere, AP HP, Med Interne, Paris, France
来源：
ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1772
引用
收藏
页码：3691 / 3691
页数：1
相关论文
共 50 条
  • [1] Treatment of EBV plus nasopharyngeal carcinoma with banked EBV-specific cytotoxic T cells
    Prockop, Susan
    Doubrovina, Ekatarina
    Baxi, Shrujal S.
    Escobedo, Virginia
    Suser, Stephanie
    Szenes, Victoria
    Pfister, David G.
    O'Reilly, Richard J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] Autologous EBV-specific cytotoxic T cells to treat EBV-associated post-transplant lymphoproliferative disease (PTLD).
    Comoli, P
    Locatelli, F
    Gerna, G
    Grossi, P
    Vigano, M
    Maccario, R
    BLOOD, 1997, 90 (10) : 1097 - 1097
  • [3] EFFECT OF INHALED CORTICOSTEROIDS ON EBV-SPECIFIC CYTOTOXIC T-CELLS AND EBV OROPHARYNGEAL EXCRETION
    ABO, W
    IMAI, S
    SUGIURA, M
    TERAI, N
    OSATO, T
    SHIMANO, Y
    CHIBA, S
    LANCET, 1992, 340 (8819): : 606 - 606
  • [4] Cell therapy with autologous EBV-specific cytotoxic T-lymphocytes for patients with nasopharyngeal carcinoma
    Comoli, P.
    Pedrazzoli, P.
    Licitra, L.
    Secondino, S.
    Gurrado, A.
    Schiavo, R.
    Basso, S.
    Schiavetto, I.
    Caruana, I.
    Maccario, R.
    Locatelli, F.
    Siena, S.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S30 - S31
  • [5] EBV-specific T cells are enriched following Autologous Stem Cell Transplant for MS
    Massey, Jennifer
    Artuz, Crisbel
    Dyer, Zoe
    Jackson, Katherine
    Khoo, Melissa
    Moore, John
    Ma, David
    Sutton, Ian
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 41 - 41
  • [6] Treatment of relapsed Hodgkin's disease using EBV-specific cytotoxic T cells
    Rooney, CM
    Roskrow, MA
    Suzuki, N
    Ng, CLC
    Brenner, MK
    Heslop, H
    ANNALS OF ONCOLOGY, 1998, 9 : 129 - 132
  • [7] T-cell Therapy Using a Bank of EBV-specific Cytotoxic T Cells: Lessons From a Phase I/II Feasibility and Safety Study
    Gallot, Geraldine
    Vollant, Solene
    Saiagh, Soraya
    Clemenceau, Beatrice
    Vivien, Regine
    Cerato, Evelyne
    Bignon, Jean-D.
    Ferrand, Christophe
    Jaccard, Arnaud
    Vigouroux, Stephane
    Choquet, Sylvain
    Dalle, Jean-Hugues
    Frachon, Irene
    Bruno, Benedicte
    Mothy, Mohamad
    Mechinaud, Francoise
    Leblond, Veronique
    Milpied, Noel
    Vie, Henri
    JOURNAL OF IMMUNOTHERAPY, 2014, 37 (03) : 170 - 179
  • [8] Characterization of αβ AND γδ T cells in clinical-grade EBV-specific T-cell products and their role in controlling EBV infection in allogeneic and autologous settings
    Mausberg, Philip
    Bonifacius, Agnes
    Tischer-Zimmermann, Sabine
    Santamorena, Maria Michela
    Dragon, Anna Christina
    Blasczyk, Rainer
    Ravens, Sarina
    Maecker-Kolhoff, Britta
    Eiz-Vesper, Britta
    HLA, 2022, 99 (05) : 474 - 475
  • [9] Characterization of αβ and γδ T cells in clinical-grade EBV-specific T-cell products and their role in controlling EBV infection in allogeneic and autologous settings
    Mausberg, P.
    Bonifacius, A.
    Tischer-Zimmermann, S.
    Santamorena, M. M.
    Dragon, A. C.
    Rahmati, P.
    Blasczyk, R.
    Ravens, S.
    Maecker-Kolhoff, B.
    Eiz-Vesper, B.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 : 363 - 364
  • [10] T cell vaccination in systemic lupus erythematosus with autologous activated T cells
    Li, ZG
    Mu, R
    Dai, ZP
    Gao, XM
    LUPUS, 2005, 14 (11) : 884 - 889
12345